Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases.

Functional brain connectivity Mild cognitive impairment due to Alzheimer's disease (ADMCI) Mild cognitive impairment due to dementia with Lewy body (DLBMCI) Resting state EEG rhythms

Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
05 2019
Historique:
received: 18 03 2018
revised: 15 01 2019
accepted: 16 01 2019
pubmed: 24 2 2019
medline: 18 12 2019
entrez: 24 2 2019
Statut: ppublish

Résumé

Previous evidence has shown different resting-state eyes-closed electroencephalographic delta (<4 Hz) and alpha (8-10.5 Hz) source connectivity in subjects with dementia due to Alzheimer's (ADD) and Lewy body (DLB) diseases. The present study tested if the same differences may be observed in the prodromal stages of mild cognitive impairment (MCI). Here, clinical and resting-state eyes-closed electroencephalographic data in age-, gender-, and education-matched 30 ADMCI, 23 DLBMCI, and 30 healthy elderly (Nold) subjects were available in our international archive. Mini-Mental State Evaluation (MMSE) score was matched in the ADMCI and DLBMCI groups. The eLORETA freeware estimated delta and alpha source connectivity by the tool called lagged linear connectivity (LLC). Area under receiver operating characteristic curve (AUROCC) indexed the classification accuracy among individuals. Results showed that widespread interhemispheric and intrahemispheric LLC solutions in alpha sources were abnormally lower in both MCI groups compared with the Nold group, but with no differences were found between the 2 MCI groups. AUROCCs of LLC solutions in alpha sources exhibited significant accuracies (0.72-0.75) in the discrimination of Nold versus ADMCI-DLBMCI individuals, but not between the 2 MCI groups. These findings disclose similar abnormalities in ADMCI and DLBMCI patients as revealed by alpha source connectivity. It can be speculated that source connectivity mostly reflects common cholinergic impairment in prodromal state of both AD and DLB, before a substantial dopaminergic derangement in the dementia stage of DLB.

Identifiants

pubmed: 30797169
pii: S0197-4580(19)30024-7
doi: 10.1016/j.neurobiolaging.2019.01.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-127

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Claudio Babiloni (C)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy; Hospital San Raffaele Cassino, Cassino (FR), Italy. Electronic address: claudio.babiloni@uniroma1.it.

Claudio Del Percio (C)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.

Maria Teresa Pascarelli (MT)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy; Oasi Research Institute - IRCCS, Troina, Italy.

Roberta Lizio (R)

IRCCS SDN, Napoli, Italy.

Giuseppe Noce (G)

IRCCS SDN, Napoli, Italy.

Susanna Lopez (S)

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.

Marco Rizzo (M)

Oasi Research Institute - IRCCS, Troina, Italy.

Raffaele Ferri (R)

Oasi Research Institute - IRCCS, Troina, Italy.

Andrea Soricelli (A)

IRCCS SDN, Napoli, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy.

Flavio Nobili (F)

Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Genova, Italy.

Dario Arnaldi (D)

Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Genova, Italy.

Francesco Famà (F)

Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Genova, Italy.

Francesco Orzi (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Carla Buttinelli (C)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Franco Giubilei (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Marco Salvetti (M)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy; Neuromed: IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed Pozzilli, Isernia, Italy.

Virginia Cipollini (V)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Raffaella Franciotti (R)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy.

Marco Onofrj (M)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy.

Paola Stirpe (P)

IRCCS San Raffaele Pisana, Rome, Italy.

Peter Fuhr (P)

Universitätsspital Basel, Abteilung Neurophysiologie, Basel, Switzerland.

Ute Gschwandtner (U)

Universitätsspital Basel, Abteilung Neurophysiologie, Basel, Switzerland.

Gerhard Ransmayr (G)

Department of Neurology 2, Med Campus III, Faculty of Medicine, Johannes Kepler University, Kepler University Hospital, Linz, Austria.

Dag Aarsland (D)

Department of Old Age Psychiatry, King's College University, London, UK.

Lucilla Parnetti (L)

Centre for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, University of Perugia, Perugia, Italy.

Lucia Farotti (L)

Centre for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, University of Perugia, Perugia, Italy.

Moira Marizzoni (M)

Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Fabrizia D'Antonio (F)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Carlo De Lena (C)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Bahar Güntekin (B)

Department of Biophysics, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Lutfu Hanoğlu (L)

Department of Neurology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Görsev Yener (G)

Department of Neurosciences and Department of Neurology, Dokuz Eylül University Medical School, Izmir, Turkey.

Derya Durusu Emek-Savaş (DD)

Department of Psychology and Department of Neurosciences, Dokuz Eylül University, Izmir, Turkey.

Antonio Ivano Triggiani (AI)

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

John Paul Taylor (JP)

Institute of Neuroscience, Newcastle University, Newcastle, UK.

Ian McKeith (I)

Institute of Neuroscience, Newcastle University, Newcastle, UK.

Fabrizio Stocchi (F)

IRCCS San Raffaele Pisana, Rome, Italy.

Laura Vacca (L)

IRCCS San Raffaele Pisana, Rome, Italy.

Harald Hampel (H)

Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Brain and Spine Institute (ICM), Paris, France.

Giovanni B Frisoni (GB)

Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland.

Maria Francesca De Pandis (MF)

Hospital San Raffaele Cassino, Cassino (FR), Italy.

Laura Bonanni (L)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH